SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-017614
Filing Date
2019-06-20
Accepted
2019-06-20 16:01:23
Documents
1
Period of Report
2019-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7264
  Complete submission text file 0000899243-19-017614.txt   8518
Mailing Address
Business Address
PIERCE GLENN (Reporting) CIK: 0001256964 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 19908572

Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations